cas 2225787-92-6|| where to buy (S)-2-(1,4-Dibenzylpiperazin-2-yl)acetonitrile

Название продукции:(S)-2-(1,4-Dibenzylpiperazin-2-yl)acetonitrile

IUPAC Name:2-[(2S)-1,4-dibenzylpiperazin-2-yl]acetonitrile

Упаковочная единица	Доступно для заказа	Цена ($)
CM335976-100mg	in stock	Ţưƞ
CM335976-250mg	in stock	ǯưĽ
CM335976-1g	1-2 Weeks	ĽŉźĽ

Только для использования в НИОКР..

Форма запроса

Химическое название

Номер CAS

Количество*

Необходимые спецификации*
(% пробы, категория материала и т.д.)

Контактное лицо*

Электронная почта*

Дополнительные примечания

Verification code*

refresh

: Номер CAS:2225787-92-6; Молекулярная формула:C20H23N3; Точка плавления:-; Smiles-код:N#CC[C@@H]1N(CC2=CC=CC=C2)CCN(CC3=CC=CC=C3)C1; Плотность:

: Номер в каталоге:CM335976; Молекулярная масса:305.42; Точка кипения:; Номер Mdl:; Хранение:2-8°C

: Piperazines; Piperazine is an organic compound consisting of a six-membered ring containing two nitrogen atoms in opposite positions in the ring. The chemical formula of piperazine is C4H10N2, and it is an important pharmaceutical intermediate. Pyrimidines and piperazines are known to be the backbone of many bulk compounds and important core structures for approved drugs; studies have shown that combining a pyridine ring with a piperazine moiety within a single structural framework enhances biological activity.

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Adagrasib; Jan. 10, 2024, EC approves KRAZATI (adagrasib) as a targeted treatment option for patients with advanced non-small cell lung cancer (NSCLC) with a KRAS G12C mutation.
Adagrasib is an orally available, potent, irreversible, small molecule inhibitor of KRAS G12C mutant isoform for the treatment of solid tumours harbouring KRAS G12C oncogenic driver mutation. Adagrasib covalently binds to the mutant cysteine in KRAS G12C and locks the mutant KRAS protein in its inactive state, thereby preventing downstream signalling without affecting wild-type KRAS protein.